Literature DB >> 15756497

[Liver and rheumatism].

C Wiegard1, A W Lohse.   

Abstract

There are multiple relations between rheumatic diseases and the liver, nevertheless the liver is extremely rare involved in rheumatic diseases. "Elevated liver enzymes" are quite often found in patients who are under the medication with immunosuppressive drugs or/and non-steroidal antirheumatics. The most frequent cause for "elevated liver enzymes" are toxic and allergic side effects of drugs; however, in rare cases it might be extremely helpful to examine, whether an independent liver disease exists. Underlying liver diseases which might be associated with the rheumatic disorder or exist accidentally may change the therapeutic management of the patient. If the liver disease present can cause the rheumatic disorder (e. g. virus-induced vasculitis, hemochromatosis), a specific hepatological therapy should precede the immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756497     DOI: 10.1007/s00393-005-0701-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  24 in total

Review 1.  Chemotherapeutic agents and hepatotoxicity.

Authors:  M C Perry
Journal:  Semin Oncol       Date:  1992-10       Impact factor: 4.929

2.  Successful treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha as first-line therapy.

Authors:  E Avşar; B Savaş; N Tözün; N B Ulusoy; C Kalayci
Journal:  J Hepatol       Date:  1998-03       Impact factor: 25.083

3.  Induction of immunological tolerance by porcine liver allografts.

Authors:  R Y Calne; R A Sells; J R Pena; D R Davis; P R Millard; B M Herbertson; R M Binns; D A Davies
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

4.  The arthropathy of idiopathic haemochromatosis.

Authors:  E Hamilton; R Williams; K A Barlow; P M Smith
Journal:  Q J Med       Date:  1968-01

5.  A debate: should patients with rheumatoid arthritis on methotrexate undergo liver biopsies?

Authors:  J M Kremer; R Koff
Journal:  Semin Arthritis Rheum       Date:  1992-06       Impact factor: 5.532

Review 6.  Hepatitis C virus-associated extrahepatic manifestations: a review.

Authors:  Damien Sène; Nicolas Limal; Patrice Cacoub
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

7.  Sjögren's syndrome in patients with primary biliary cirrhosis.

Authors:  E V Tsianos; J H Hoofnagle; P C Fox; M Alspaugh; E A Jones; D F Schafer; H M Moutsopoulos
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

Review 8.  Hepatocellular damage from non-steroidal anti-inflammatory drugs.

Authors:  N O'Connor; P I Dargan; A L Jones
Journal:  QJM       Date:  2003-11

9.  Autoimmune hepatitis in a patient with systemic lupus erythematosus.

Authors:  M Iwai; Y Harada; M Ishii; S Tanaka; A Muramatsu; T Mori; T Nakashima; T Okanoue; S Hirohata
Journal:  Clin Rheumatol       Date:  2003-09       Impact factor: 2.980

10.  Autoimmune hepatitis accompanied by systemic lupus erythematosus.

Authors:  Jun Tojo; Hiromasa Ohira; Kazumichi Abe; Junko Yokokawa; Junko Takiguchi; Tsuyoshi Rai; Shoichiro Shishido; Yukio Sato; Reiji Kasukawa
Journal:  Intern Med       Date:  2004-03       Impact factor: 1.271

View more
  3 in total

1.  [Differential diagnosis of elevated liver transaminases in rheumatic diseases].

Authors:  W-J Mayet
Journal:  Z Rheumatol       Date:  2015-03       Impact factor: 1.372

2.  [Comorbidity of rheumatic and hepatic diseases].

Authors:  W-J Mayet; A W Lohse
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

3.  [Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report].

Authors:  U Hartmann; S Schmitt; M Reuss-Borst
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.